Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Izzy who wrote (2978)	11/24/1997 11:39:00 PM
From: JOHN W.	Read Replies (2) \| Respond to of 6136

Subject: Scrip numbers Date: Mon, Nov 24, 1997 21:48 EST From: CutNSew Message-id: <19971125024801.VAA23206@ladder01.news.aol.com> For what it's worth after a trying day for AGPH shareholders, the scrip nos. for the week ending 11/14/97 continue to look strong. New: 3386 Refills: 5465 Total: 8851

To: Izzy who wrote (2978)	11/25/1997 12:51:00 AM
From: billkirn	Read Replies (1) \| Respond to of 6136

Izzy: Haven't read the article. The concept that there would be some kind of value to rebut the article from anyone other than key recognized industry analysis is a little wishful thinking. I have requested the company clarify their progress and provide their analysis of up coming competition. This statement would need to be independent of any article. Even this would be unusual, since they might estabish a precedent to respond to these kinds of statements. This would become an untenable position. I think John is advocating AGPH's position very well. Lets hope the pull back stops soon. Remember the long term prospects are good and the management team is the best. Bill Kirn